| Q3'26 · quarter ended 2026-09-30 | $75M- Exact value
- $75,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2026-07-01 to 2026-09-30
- Accession
- 0000049071-26-000066
- Form
- 10-Q
- Filed
- 2026-11-06
- Derivation
- direct
- Filing
- SEC filing index
| $400M | -81.3% |
|---|
| Q2'26 · quarter ended 2026-06-30 | $1.4B- Exact value
- $1,360,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2026-04-01 to 2026-06-30
- Accession
- 0000049071-26-000050
- Form
- 10-Q
- Filed
- 2026-07-29
- Derivation
- direct
- Filing
- SEC filing index
| $1.1B | 23.9% |
|---|
| Q1'26 · quarter ended 2026-03-31 | $1.8B- Exact value
- $1,754,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2026-01-01 to 2026-03-31
- Accession
- 0000049071-26-000023
- Form
- 10-Q
- Filed
- 2026-04-29
- Derivation
- direct
- Filing
- SEC filing index
| $2B | -12.9% |
|---|
| Q3'25 · quarter ended 2025-09-30 | $400M- Exact value
- $400,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2025-07-01 to 2025-09-30
- Accession
- 0000049071-26-000066
- Form
- 10-Q
- Filed
- 2026-11-06
- Derivation
- direct
- Filing
- SEC filing index
Other filings for this period - 0000049071-25-000057 10-Q filed 2025-11-05
| $728M | -45.1% |
|---|
| Q2'25 · quarter ended 2025-06-30 | $1.1B- Exact value
- $1,098,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2025-04-01 to 2025-06-30
- Accession
- 0000049071-26-000050
- Form
- 10-Q
- Filed
- 2026-07-29
- Derivation
- direct
- Filing
- SEC filing index
Other filings for this period - 0000049071-25-000042 10-Q filed 2025-07-30
| $1.1B | -3.8% |
|---|
| Q1'25 · quarter ended 2025-03-31 | $2B- Exact value
- $2,014,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2025-01-01 to 2025-03-31
- Accession
- 0000049071-26-000023
- Form
- 10-Q
- Filed
- 2026-04-29
- Derivation
- direct
- Filing
- SEC filing index
Other filings for this period - 0000049071-25-000023 10-Q filed 2025-04-30
| $1.2B | 62.9% |
|---|
| Q3'24 · quarter ended 2024-09-30 | $728M- Exact value
- $728,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2024-07-01 to 2024-09-30
- Accession
- 0000049071-25-000057
- Form
- 10-Q
- Filed
- 2025-11-05
- Derivation
- direct
- Filing
- SEC filing index
Other filings for this period - 0000049071-24-000055 10-Q filed 2024-10-30
| $1.2B | -39.6% |
|---|
| Q2'24 · quarter ended 2024-06-30 | $1.1B- Exact value
- $1,141,000,000 USD
- Metric
- Operating income (GAAP)
- Scope
- GAAP, consolidated
- XBRL concept
- OperatingIncomeLoss
- Period
- 2024-04-01 to 2024-06-30
- Accession
- 0000049071-25-000042
- Form
- 10-Q
- Filed
- 2025-07-30
- Derivation
- direct
- Filing
- SEC filing index
Other filings for this period - 0000049071-24-000040 10-Q filed 2024-07-31
| $1.4B | -20.5% |
|---|